Psoriasis Club
  • Forum
  • Home
  • Portal
  • Member List
  • Psoriasis Score
  • PQOLS
  • What is psoriasis
  • Search
  • Help
Hello Guest, Welcome To The Psoriasis Club Forum. We are a self funded friendly group of people who understand.
Never be alone with psoriasis, come and join us. (Members see a lot more than you)
wave
Login Register
Login
Username:
Password:
Lost Password?
 
Psoriasis Club › HealthHealth Boards › Psoriasis In The News v
« Previous 1 … 28 29 30 31 32 … 54 Next »

Prevalence of non plaque psoriasis phenotypes

Threaded Mode
Prevalence of non plaque psoriasis phenotypes
Fred Offline
I Wanted To Change the World But Got Up Far Too Late.
Moderator
Posts: 66,956
Threads: 3,888
Joined: Aug 2011
Gender: Male
Location: France
Psoriatic Arthritis Score: 1
PQOLS: 1
Treatment: Bimzelx / Coconut Oil
#1
News  Thu-18-02-2016, 21:11 PM
This study looked at the prevalence of nonplaque psoriasis phenotypes. Data was obtained from three prospective cohort studies of 3179 women and 646 men.

Quote:
Background:
We present the largest set of US prevalence data for psoriasis to date, obtained from three prospective cohort studies describing validated clinical phenotypes of psoriasis, including novel data about the prevalence of inverse (intertriginous) psoriasis in these groups. Nonplaque psoriasis phenotypes have been largely unmeasured in observational and interventional studies, and this has led to an under-recognition of this aspect of psoriatic disease.

Aim:
To describe the prevalence of nonplaque psoriasis phenotypes in a large prospective cohort.

Methods:
We included 3179 women and 646 men in the analysis. Participants in the Nurses Health Study (NHS) and Health Professionals Follow-up Study (HPFS) with physician-diagnosed psoriasis completed a validated, self-administered questionnaire to assess plaque and nonplaque subsets of psoriasis.

Results:
Psoriasis phenotypes were as follows: plaque 55%, scalp 52%, palmar–plantar 14%, nail 23% and inverse 21% in the NHS (n = 1604); plaque 60%, scalp 56%, palmar–plantar 16%, nail 27% and inverse 24% in the second NHS study (NHS II) (n = 1575); and plaque 55%, scalp 45%, palmar–plantar 12%, nail 27% and inverse 30% in the HPFS (n = 646). Scalp, nail, palmar–plantar and inverse disease represent highly prevalent phenotypes of psoriasis in the USA.

Conclusion:
Scalp, nail, palmar–plantar and inverse disease represent highly prevalent phenotypes of psoriasis.

Source: onlinelibrary.wiley.com

Funding: National Institutes of Health
Quote
« Next Oldest | Next Newest »


Possibly Related Threads…
Thread Author Replies Views Last Post
News Wynzora gets FDA approval for plaque psoriasis Fred 2 3,357 Thu-23-07-2020, 06:20 AM
Last Post: Caroline
News Long term efficacy and safety results for Taltz in Japanese plaque psoriasis Fred 0 2,463 Wed-17-10-2018, 11:04 AM
Last Post: Fred
News Bryhali gets tentative FDA approval for plaque psoriasis Fred 1 3,097 Tue-09-10-2018, 05:15 AM
Last Post: Imapsomom
News Prevalence of biological liver test abnormalities in psoriasis patients Fred 1 3,447 Thu-26-05-2016, 20:54 PM
Last Post: Caroline
News Psoriasis Study says higher risk of non alcoholic fatty liver disease. Fred 1 3,296 Wed-12-08-2015, 06:58 AM
Last Post: Quest4Cure



Users browsing this thread: 1 Guest(s)
    About | Contact us | Login | Register | Home | Cookies/GDPR | RSS Syndication | Portal | Types Of Psoriasis | Psoriasis Score | Members Only Boards
    Copyright © 2010 - 2025 Psoriasis Club | All Rights Reserved | Founded May 2010 | Psoriasis Club Is Self Funded Without Sponsors Or Donations | Software by MyBB | Social
Linear Mode
Threaded Mode